News - 25 Jan `22VALIANT: New Perspectives On Vitiligo at Maui Derm


This week, January 24 to 28, the Maui Derm for Dermatologists conference will be held in Maui, Hawaii, and virtually.

The team of vitiligo researchers will be presenting Global VALIANT Natural History abstract poster titled “Exploring the natural and treatment history of vitiligo: Findings from the global VALIANT study.” 

The Vitiligo and Life Impact Among International Communities (VALIANT) study sought to understand the natural history of vitiligo among patients around the world as well as the patient journey with vitiligo. The survey included over 3500 patients from 17 countries. Study findings provide a new perspective on the diagnosis and treatment journey for patients with vitiligo globally. VR Foundation is proud to a be part of this important study.  

Here are other virtual poster presentations from the GVF annual scientific symposium on vitiligo:

  • Combined fractional CO2 laser and tacrolimus ointment therapy in treatment-resistant acral vitiligo. Hatoun Almaziad, Prince Sultan Medical Military City in Riyadh
  • Comparison between the efficacy of microneedling combined with 5-fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo. Drs Mary Mina, Lamia Elgarhy, Hanan Al-saeid and Zeinab Ibrahim; Tanta University
  • La pandemia COVID-19 y su impacto en la propagación del vitiligo: un estudio transversal en México. German Guerrero-Oliva, Jessica Sulema Rodarte-Acosta, María Luisa Peralta-Pedrero et al.
  • Demographics and Baseline Clinical Characteristics of Patients Enrolled in 2 Randomized, Double-Blind, Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo, Pearl Grimes, Seemal R. Desai, Richard H. Huggins, et al.
  • Efficacy of 308-nm Excimer Lamp (MEL) in Association with Topical Tacrolimus Ointment for Vitiligo. Celso Lopes. São Paulo, Brazil
  • Starting and Running a Vitiligo Support Group: Lessons from Current Leaders. Amaris Geisler, Amanda Milburn, Katie O’Connell et al.
  • Prevalence of Vitiligo Among a Nationally Representative Sample of Adults in the United States. Khaled Ezzedine, Kathryn P. Anastassopoulos, Kavita Gandhi et al
  • Prevalence of Vitiligo Among Children/Adolescents in the United States. Amit G. Pandya, Kavita Gandhi, Reema Patel et al.
  • Protocol for Performing Reflectance Confocal Imaging for Vitiligo Patients: A Pilot Study. Nneamaka Ezekwe, Indermeet Kohli, Dilara Turk et al.
  • Psychological Impact of COVID-19 Pandemic in Vitiligo: Depression and Anxiety. German Guerrero-Oliva, Jessica Sulema Rodarte-Acosta, María Luisa Peralta-Pedrero et al.
  • Self-Reported Comorbidities Among Adults With Vitiligo in the United States. Henri Mondor University Hospital
  • Social Media Platforms and Google Trends as a Resource for Vitiligo Support. Rayva Khanna BA, Wyatt Boothby-Shoemaker BA, Raveena Khanna et al.
  • The Association of Demographic and Clinical Characteristics With HRQoL in Adults With NSV in the US. Kavita Gandhi, Shoshana R. Daniel, Amit G. Pandya et al. 
  • The Long-term Risk of Lymphoma and Skin Cancer After Topical Calcineurin Inhibitor Use and Phototherapy in a Cohort of 25,694 Patients with Vitiligo. Hyun Jeong Ju, Ju Hee Han, and Jung Min Bae
  • Utilization of the Vitiligo Area Scoring Index (VASI) as a Measure of Outcomes in Vitiligo. Elizabeth A Warbasse, Aunna Pourang, and Iltefat Hamzavi.
  • Vitiligo, Nutrition and the Gastrointestinal Microbiome. Karan Pandher, Indraneel Prabhu, Aunna Pourang, Richard H. Huggins
  • World Vitiligo Day 2020: A Community Perspective. Katie A. O’Connell, Ronnie M. Youssef, Angeli Eloise Torres et al. 

Additional reading: Vitiligo Patient Journey Map